Abstract
The placement of an intrathecal catheter, tunneling of the catheter, pocketing for pump placement, and connection of the system is a complex process of interventions requiring great technical skill, but it can be argued that the selection of the patient who will receive the pump is of even greater importance. A device placed for the wrong indication in the wrong patient may provide disappointing results. Selection considers patient characteristics; indications consider the disease state being treated. This chapter focuses on proper patient selection for implantation of intrathecal drug infusion systems
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Suggested Reading
Deer T, Winkelmüller W, Erdine S, Bedder M, Burchiel K. Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management. Neuromodulation. 1999;2:55–66.
Deer T, Krames E, Hassenbusch S, Burton A, Caraway D, Dupen S, et al. Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation. 2007;10:300–28.
Deer TR, Prager J, Levy R, Burton A, Buchser E, Caraway D, et al. Polyanalgesic Consensus Conference – 2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation. 2012;15:420–35.
Hassenbusch SJ, Portenoy RK, Cousins M, Buchser E, Deer TR, Du Pen SL, et al. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery–report of an expert panel. J Pain Symptom Manage. 2004;27:540–63.
Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB. Intrathecal therapy for cancer and noncancer pain. Pain Physician. 2011;14:219–48.
Krames ES. Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines. J Pain Symptom Manage. 1996;11:333–52.
Pope JE, Deer TR. Ziconotide: a clinical update and pharmacologic review. Expert Opin Pharmacother. 2013;14:957–66.
Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, et al.; Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20:4040–9
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Deer, T.R., Pope, J.E. (2016). Selection and Indications for Intrathecal Pump Placement. In: Deer, T., Pope, J. (eds) Atlas of Implantable Therapies for Pain Management. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2110-2_36
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2110-2_36
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2109-6
Online ISBN: 978-1-4939-2110-2
eBook Packages: MedicineMedicine (R0)